Get the latest market trends in your inbox
Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul
Tampa-St. Petersburg news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg
A Regal box office. Photo: Jeff Greenberg/UIG via Getty Images
Sinemia, a movie theater subscription service, is starting to gain steam in the United States as its primary competitor, MoviePass, enters uncertain financial waters thanks to its cash-hemorrhaging model that offers one movie per day for $10 a month, per Wired.
The big picture, from Axios' Sara Fischer: Shares for MoviePass' parent company Helios and Matheson plunged yesterday after the company basically conceded that MoviePass' structure is forcing it to burn through cash. And the service's spending might continue to balloon: MoviePass CEO Mitch Lowe told Axios earlier this year that he expects the subscriber growth for the company to continue — at a rate of 80,000 to 120,000 new subscribers a week.